The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

0301 basic medicine Science Medizin 610 Animals; Carrier Proteins/metabolism; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms/genetics; Dyneins/metabolism; Gene Expression Regulation, Neoplastic; Hedgehog Proteins/genetics; Hedgehog Proteins/metabolism; Humans; Medulloblastoma/genetics; Membrane Glycoproteins/metabolism; Mice; MicroRNAs/genetics; RNA, Long Noncoding/genetics Article Mice 03 medical and health sciences Cell Line, Tumor [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology Animals Humans Hedgehog Proteins /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being Cerebellar Neoplasms Cell Proliferation Membrane Glycoproteins Q Dyneins 3. Good health Gene Expression Regulation, Neoplastic MicroRNAs RNA, Long Noncoding Carrier Proteins info:eu-repo/classification/ddc/500 Medulloblastoma
DOI: 10.1038/s41467-022-31574-z Publication Date: 2022-07-13T21:29:08Z
ABSTRACT
Most lncRNAs display species-specific expression patterns suggesting that animal models of cancer may only incompletely recapitulate the regulatory crosstalk between and oncogenic pathways in humans. Among these pathways, Sonic Hedgehog (SHH) signaling is aberrantly activated several human entities. We unravel aberrant primate-specific lncRNA HedgeHog Interacting Protein-AntiSense 1 (HHIP-AS1) a hallmark SHH-driven tumors including medulloblastoma atypical teratoid/rhabdoid tumors. HHIP-AS1 actively transcribed from bidirectional promoter shared with SHH regulator HHIP. Knockdown induces mitotic spindle deregulation impairing tumorigenicity vitro vivo. Mechanistically, binds directly to mRNA cytoplasmic dynein intermediate chain 2 (DYNC1I2) attenuates its degradation by hsa-miR-425-5p. uncover neither nor corresponding element DYNC1I2 are evolutionary conserved mice. Taken together, we discover an lncRNA-mediated mechanism enables pro-mitotic effects pathway activation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (22)